LONDON--(BUSINESS WIRE)--The global Behcet's disease therapeutics market size is poised to grow by USD 224.55 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of more than 6% during the forecast period.
Read the 150-page research report with TOC on "Behcet’s Disease Therapeutics Market Analysis Report by product (small molecules, and biologics), and geography (North America, Europe, Asia, and ROW) 2019 - 2023". Request a Free Sample Report
The market is driven by the increase in research funding for rare diseases. In addition, the special drug designations are expected to further boost the growth of the Behcet's disease therapeutics market.
The increasing prevalence of Behcet's disease and the lack of approved therapies has resulted in an unmet need for the treatment of this disease. As a result, vendors and research institutions are carrying out intense R&D to develop novel therapies for the treatment for Behcet’s disease. Thus, the increased research funding is expected to fuel the growth of Behcet’s disease therapeutics market during the forecast period.
Regulatory authorities are awarding special drug designations to the drugs that treat Behcet’s disease and therapeutic candidates that are currently under development for the treatment of the condition. Special designations such as breakthrough drug designation, orphan drug designation, help to enhance research and enable drugs to reach the market at the earliest. Thus, special drug designations are likely to fuel the growth of the market during the forecast period.
For More Information: Request Free Sample Pages
The report includes detailed profiles of the leading companies & prominent vendors of the market:
- AbbVie Inc.
- Amgen Inc.
- Celgene Corp.
- Eisai Co. Ltd.
- F. Hoffmann-La Roche Ltd.
Market Segmentation by End-User:
Behcet’s disease therapeutics market can be broadly categorized into the following segments:
- Small molecules
- Biologics
Key Regions for the Behcet’s Disease Therapeutics Market:
Featuring a breakdown of region-wise market shares until 2019.
- North America
- Europe
- Asia
- ROW
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health care are:
Kidney Stones Management Devices Market – Global Kidney Stones Management Devices Market by procedure (URS, ESWL, and PCNL) and geography (Asia, Europe, North America, and ROW).
Polycystic Kidney Disease Drugs Market – Global Polycystic Kidney Disease Drugs Market by type (ADPKD and ARPKD) and geography (Asia, Europe, North America, and ROW).
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
